AVGO
69
-7
AAPL
58
-3
CHK
10
3
NEE
46
5
FOXA
38
4
PRGO
39
2
TGNA
56
3
FAST
52
2
WY
36
-3
NSC
54
4
STI
3
2
ISRG
78
-3
D
37
5
AAP
24
4
SYK
60
-10
SWKS
66
7
EXR
57
-2
MET
60
3
UPS
46
5
HUM
35
6
AVGO
69
-7
AAPL
58
-3
CHK
10
3
NEE
46
5
FOXA
38
4
PRGO
39
2
TGNA
56
3
FAST
52
2
WY
36
-3
NSC
54
4
STI
3
2
ISRG
78
-3
D
37
5
AAP
24
4
SYK
60
-10
SWKS
66
7
EXR
57
-2
MET
60
3
UPS
46
5
HUM
35
6
Financhill
Back

Esquire Financial Holdings Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
14

ESQ
Esquire Financial Holdings

Last Price:
44.75
Seasonality Move:
0.89%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
14
Esquire Financial Holdings (ESQ) is a Sell

Is Esquire Financial Holdings a Buy, Sell or Hold?

  • The current Esquire Financial Holdings [ESQ] share price is $45.55. The Score for ESQ is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • ESQ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ESQ Stock Price Chart

What is Esquire Financial Holdings's stock price today?

  • The Esquire Financial Holdings share price today is $45.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ESQ is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

ESQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 39.52 Sell
Chaikin Money Flow: -595 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.66 - 47.82) Sell
Bollinger Bands (100): (46.09 - 49.75) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

ESQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.22 Sell
20-day SMA: 46.3 Sell
50-day SMA: 47.1 Sell
200-day SMA: 47.5 Sell
8-day EMA: 46.01 Sell
20-day EMA: 46.48 Sell
50-day EMA: 47.07 Sell
200-day EMA: 47.01 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

Esquire Financial Holdings Earnings Growth & ESQ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.08 per share, an increase this year of $0.35 per share, and an increase next year of $0.51 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Esquire Financial Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):